Teufel Crispin 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Teufel Crispin
Director
Transactions
- Award
Stock Options (right to buy)
2021-12-31$3.10/sh+21,828$67,667→ 33,087 totalExercise: $3.10From: 2022-12-31Exp: 2031-12-31→ Common Stock (21,828 underlying)